A retrospective study of efficacy and safety of Ustekinumab and Vedolizumab in Crohn's Disease
Latest Information Update: 07 Dec 2020
At a glance
- Drugs Ustekinumab (Primary) ; Vedolizumab (Primary)
- Indications Crohn's disease
- Focus Adverse reactions; Therapeutic Use
- 07 Dec 2020 New trial record
- 13 Oct 2020 Results presented at the 28th United European Gastroenterology Week